Metraipolis › archive › dc_72c2f1cdefd2
Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis — Europe PMC PMID:42525900
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42525900
- DOI
- 10.1212/wnl.0000000000218379
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-17T10:50:27.178Z
- SHA-256 of the archived text
3e1bfbf2c7bf4351778fedbb406d3f06857764115900fcb1e730e24b3d4d1abb- Stable URL of this page
https://metraipolis.com/documento/dc_72c2f1cdefd2
How to cite
Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis — Europe PMC PMID:42525900 — Europe PMC (en), https://europepmc.org/article/MED/42525900 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72c2f1cdefd2 (Metraipolis archive dc_72c2f1cdefd2, sha256 3e1bfbf2c7bf4351778fedbb406d3f06857764115900fcb1e730e24b3d4d1abb)
BibTeX
@misc{dc72c2f1cdefd2,
title = {Value of Annual MRI Monitoring in Patients With Multiple Sclerosis Treated With Ocrelizumab: A Number Needed to Scan Analysis — Europe PMC PMID:42525900},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42525900},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72c2f1cdefd2; sha256 3e1bfbf2c7bf4351778fedbb406d3f06857764115900fcb1e730e24b3d4d1abb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42525900. Agents can read the archived copy with the MCP tool read_document.